Date of publication: January 16,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/FR/06/01/06
Member State: France
Date of Acknowledgement: 12/12/2005
Title of the Project:
Application for the deliberate release of genetically
modified NK603 (MON-ØØ6Ø3-6) maize
Proposed period of release From:01/04/2006
To:31/12/2009
Name of the Institute(s) or Company(ies): Pioneer
Genetique;
3. Is the same GMPt release planned elsewhere in the
Community?
No
4 - Has the same GMPt been notified elsewhere by the same
notifier?
No
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
|
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
| maize
|
poaceae |
zea
|
zea
mays |
mays
|
experimental varieties |
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
NK603 maize has been genetically modified to tolerate
application of glyphosate herbicide, which allows the farmers to
use a broad-spectrum, non-selective, systemic herbicide for the
weeding of the maize fields.
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
NK603 maize, from Monsanto, has been genetically modified by
the introduction of the cp4epsps gene, from Agrobacterium sp.
strain CP4, that confers tolerance to glyphosate herbicide,
along with the regulatory components necessary for expression in
maize plant:
- the cp4epsps gene, the P-ract1/ract1 intron + ctp2, the NOS 3’
terminator.
- the cp4epsps gene, the CaMV e35S promoter + Zmhsp70 + ctp2,
the NOS 3’ terminator.
6. Brief description of the method used for the genetic
modification:
The genetic modification was done using particle acceleration
method by Monsanto. Subsequently, maize plants tested in the
trials have been obtained by traditional breeding.
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Not applicable.
Experimental
Release
1. Purpose of the release:
The purpose of the release is to collect additional data on
NK603 maize varieties. Studies will be carried out to observe
the plant behavior, the herbicide application effects and the
expression of the genes introduced in comparison with
genetically modified maize combinations containing NK603 maize.
2. Geographical location of the site:
The releases are planned at several locations in France
within the following areas: Nord-Pas-de-Calais (Nord), Picardie
(Aisne, Oise, Somme), Bourgogne (Saône et Loire), Rhône-Alpes
(Ain, Isère, Drome), Centre (Eure et Loir, Loir et Cher, Indre,
Indre et Loire, Loiret), Aquitaine (Landes, Lot et Garonne),
Midi-Pyrénées (Haute-Garonne, Gers, Tarn, Tarn et Garonne),
Languedoc-Roussillon (Aude).
3. Size of the site (m2):
Every year, there could have up to 12 sites of release, each
sown with up to 5000 m² of genetically modified NK603 maize
subject of this notification. Other genetically modified maize
may be planted on the same sites of release. Thus, the total
trial surface for each site (all varieties and borders included)
will be larger.
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Field trials have already been conducted in several locations
with this genetically modified maize and no environmental
problems were reported for these trials. The transgenic plants
have appeared normal in all respects. They were
indistinguishable from the non-genetically modified maize
plants, except for showing herbicide tolerance when glyphosate
is applied, trait due to the genetic modification.
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
No risks to human and animal health or to the environment
from the deliberate release of genetically modified maize
tolerant to glyphosate are expected, as per information
contained in Summary Notification Information Format of
notification C/ES/03/01.
Brief description of any measures taken for the management of
risks:
The shedding of pollen from the genetically modified plants
will be controlled by maintaining a 200-meter isolation distance
with any other non-experimental maize crop. In addition, the
trial will be surrounded by four border rows of conventional
maize of a similar relative maturity that will be also destroyed
at the end of the release.
Seed dispersal of individual kernels does not generally occur.
They are fixed on a cob and enclosed in many husks that protect
the seeds from outside contact. When a few seeds need to be
collected for analysis; this will be done by sampling the whole
ear and unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by
application of a non-selective herbicide other than glyphosate
or by mechanical destruction and incorporation into the soil.
At the end of the release, all remaining plant matter that has
not been harvested for analyses will be destroyed by chopping
and incorporating into the soil. No plant or plant product
coming from the trials will enter the food or feed chains.
Volunteer maize will be monitored during the following year. An
herbicide treatment (other than glyphosate) will be used in
order to ensure destruction if needed.
No commercial maize will be cultivated in the trial site the
following year.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Not applicable to this release.
Final report
-
European
Commission administrative information
Consent given by the Competent
Authority: Not Known |
